Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Bartolozzi

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Bioorganic & Medicinal Chemistry Letters|January 11, 2015
Selective CB2 receptor agonists. Part 3: the optimization of a piperidine-based series that demonstrated efficacy in an in vivo neuropathic pain modelAlessandra Bartolozzi, Pier Francesco Cirillo, Angela K Berry, et al.
The Journal of Organic Chemistry|January 7, 2015
Development of an asymmetric synthesis of a chiral quaternary FLAP inhibitorKeith R Fandrick, Jason A Mulder, Nitinchandra D Patel, et al.
Journal of Medicinal Chemistry|February 12, 2015
Synthesis, SAR, and series evolution of novel oxadiazole-containing 5-lipoxygenase activating protein inhibitors: discovery of 2-[4-(3-{(r)-1-[4-(2-amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915)Hidenori Takahashi, Doris Riether, Alessandra Bartolozzi, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Bioorganic & Medicinal Chemistry Letters|January 11, 2015
Selective CB2 receptor agonists. Part 3: the optimization of a piperidine-based series that demonstrated efficacy in an in vivo neuropathic pain modelAlessandra Bartolozzi, Pier Francesco Cirillo, Angela K Berry, et al.
The Journal of Organic Chemistry|January 7, 2015
Development of an asymmetric synthesis of a chiral quaternary FLAP inhibitorKeith R Fandrick, Jason A Mulder, Nitinchandra D Patel, et al.
Journal of Medicinal Chemistry|February 12, 2015
Synthesis, SAR, and series evolution of novel oxadiazole-containing 5-lipoxygenase activating protein inhibitors: discovery of 2-[4-(3-{(r)-1-[4-(2-amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915)Hidenori Takahashi, Doris Riether, Alessandra Bartolozzi, et al.
Pageof 2